Oklahoma Telemedicine Conference 
2014 
David E. Albert, MD 
Founder and Chief Medical Officer 
AliveCor 
The mCardiology Company 
1 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Disclaimer 
Statements, opinions and results of studies contained in 
the program are those of the presenters/authors and do 
not reflect the policy or position of the Board of Regents 
of the University of Oklahoma (“OU”) nor does OU 
provide any warranty as to their accuracy or reliability. 
Every reasonable effort has been made to faithfully 
reproduce the presentations and material as submitted. 
However, no responsibility is assumed by OU for any 
claims, injury and/or damage to persons or property 
from any cause, including negligence or otherwise, or 
from any use or operation of any methods, products, 
instruments or ideas contained in the material herein. 
2 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Disclosure Statement of Financial Interest 
Within the past 12 months, I or my spouse/partner have had a financial 
interest/arrangement or affiliation with the organization(s) listed below. 
Affiliation/Financial Relationship Company 
• Major Stock Shareholder/Equity 
• Ownership/Founder 
• Salary & Other Financial Benefit 
3 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
• AliveCor, Inc.
Objectives 
• Describe the current status of healthcare delivery in 
the US and OUS 
• Describe how mHealth can help address some of the 
global issues 
• Describe the current status of mHealth in the US and 
OUS 
• Provide real-world examples of how mHealth is 
working 
• Describe the potential in the future 
4 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
US Healthcare Expenditures 
5 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Expenditures Continue to Increase 
6 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
7 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Healthcare Problems Differ For the Developed 
vs. the Developing World 
• Developed world (especially the US) spends too 
much on healthcare and doesn’t get its money’s 
worth. 
• Developing world spends too little and gets 
exactly what it pays for (i.e., almost nothing). 
• We must find solutions and technologies which 
can address the problems of both… and that’s 
not as crazy as it sounds! 
8 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Population Growth (in the Developing World) Demands Action 
to Improve Healthcare! 
9 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
10 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Healthcare Globally Must Go from Reactive to 
Proactive: Hygiene & Diet & Fitness & Vaccines, Etc. 
11 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Inadequate Healthcare Access 
Global HC workforce vs. disease burden* The challenge 2013 
12 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
57 
Countries below WHO critical 
healthcare coverage threshold 
4.3 million 
Worldwide shortage of health workers 
including doctors, nurses, and midwives 
$2 billion 
Annual cost just for training of needed 
U.S., Canada, and Latin America have 37% of global HC professionals in India alone 
healthcare workers and only 10% of global disease 
burden 
*: Size of circles proportional to healthcare expenditures 
Source: World Health Organization 
AliveCor Company Confidential Oct-14
Health Data, like All Information, will be 
Shared, Connected & Engaged 
*: 1 exabyte = 109 gigabytes 
Source: Cisco VNI Mobile 2011 
92% CAGR 
13 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
And Exponential Change will bring a 
New Paradigm to Healthcare 
14 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphones Introduced Apps & As the Late 
Steve Jobs said, “That changed everything”! 
• > 1 Billion Apple and Android 
devices sold to date 
worldwide 
• Over 70% of US subscribers 
have a smartphone 
• 100 billion app downloads 
from Apple’s iTunes Store & 
Android Market 
• 5 years from now there will be 
no dumb phones but only 
smartphones 
15 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphones: The Global Technology Growth Engine 
mHealth: Bringing Smartphone Dynamics to Medicine 
75 
38 
13 
16 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
4 2.5 
mHealth by 2017 
Telephone Radio TV Internet Smartphone 
Years to reach 50 Million Users 
500M 
$26B 
Users 
Market 
size
The Smartphone Will be the World’s Healthcare 
Portal 
17 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphone ownership by demographic group— 
gender, age, race/ethnicity 
% within each group who own a smartphone 
18 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Own a smartphone 
All adults (n=2,252) 56% 
Gender 
Men (n=1,029) b 
a 59 
b Women (n=1,223) 53 
Age 
a 18-24 (n=243) 79 
cdef 
b 25-34 (n=284) 81 
cdef 
c 35-44 (n=292) 69 
def 
d 45-54 (n=377) 55 
ef 
e 55-64 (n=426) 39 
f 
f 65+ (n=570) 18 
Race/ethnicity 
a White, Non-Hispanic (n=1,571) 53 
b Black, Non-Hispanic (n=252) 64 
a 
c Hispanic (n=249) 60 
Source: Pew R e s earch Center’s Internet m& A erican Life Projectp, A ril 
17-May 19, 2013 Tracking Survey. Interviews were conducted in English 
and Spanish and on landline and cell phones. Margin of error is +/-2.3 
percentage points based on all adults (n=2,252). 
Note: Percentages marked with a superscript letter (e.g., a) indicate a
19 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphone ownership by income/age grouping 
% within each age/income grouping who own a smartphone (example: 77% of 18-29 
year olds with an annual household income of less than $30,000 are smartphone 
owners) 
77% 
47% 
100% 
80% 
60% 
40% 
20% 
Source: Pew R e s earch Center’s Internet &m A erican Life Project 6April 2 -May 22, 
2011, January 20-February 19, 2012, and April 17-May 19, 2013 tracking surveys. For 
2013 data, n=2,252 adults and survey includes 1,127 cell phone interviews. All surveys 
include Spanish-language interviews. 
20 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
22% 
8% 
81% 
68% 
40% 
21% 
90% 
87% 
72% 
43% 
0% 
18-29 30-49 50-64 65+ 
Less than $30,000 $30,000-$74,999 $75,000 or more
21 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
22 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Physicians & Mobile Computing 
Devices 
Source: QuantiaMD, Tablets Set to Change Medical Practice, 2011 
23 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Physicians Support Mobile Monitoring 
• Percentage who want to monitor patients at home 
24 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
65% - Weight 
61% - Blood sugar 
57% - Vital signs (e.g. blood pressure, 
heart rate, respiratory rate) 
54% - Exercise/physical activity 
36% - Calories/fat content taken in 
36% - Pain level 
35% - Sleep patterns 
28% - Cardiac rhythm 
17% - Bladder control 
16% - Acid reflux/indigestion 
13% - Digestive health 
Source: PricewaterhouseCoopers HRI Physician Survey, 2010
Patients Accept Ownership 
and Responsibility 
Source: IBM Report: The Future of Connected Health 
Devices, March 2011 
“Among those surveyed, nine out of ten (93 percent) are 
satisfied or very satisfied with the basic functionality of their 
devices. Although less than 10 percent are paying out-of-pocket 
charges for their devices today, more than one-third 
expect to do so within two years. Most users are willing to pay 
for a device, but will not spend more than US$100 out of 
pocket. An increasing number of consumers also 
anticipate paying monthly fees in the future; while only 5 
percent pay a monthly charge today, 35 percent expect to do so 
in two years.” 
AliveCor Company Confidential May 2011 
25 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Highlights 
A Huge Opportunity To Do Good & Do Well! 
PwC and GSMA predicts 
that global mHealth 
revenues will increase to 
$23 billion over the next 
four years 
26 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
The market opportunity
Global mHealth Market Relevance 
US & Western Europe 
 Empower consumers 
 Improve effectiveness of existing 
systems 
 Reduce costs 
27 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Developing World 
 Create health infrastructure 
 Leap-frog bricks and mortar 
 Provide accessible health solutions
28 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
29 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
30 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
31 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
32 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
33 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
34 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
35 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
36 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
37 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
38 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Outcomes are Improved When We Connect 
39 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
App-Drug Synergy will Enable Patient 
Self-Management 
• Diabetes: Sanofi iBGStar 
• Hypertension: Withings BP 
• Atrial Fibrillation: AliveCor ECG 
40 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphone & Cloud Computing Enable Global 
Telemedicine 
41 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Smartphones & Big Data Will Rely on CLOUD 
COMPUTING To Create Connected Innovations! 
42 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
BIG DATA will allow innovation in everything 
from weather to energy to medicine! 
43 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
H1N1 Virus 
44 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
1919 Spanish Influenza Epidemic 
45 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
The New Vectors of Social Virality 
46 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Idea Epidemics can Literally Span the Globe in a Day 
47 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Ideas Spread At the Speed of Light With No Control 
48 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Cardiovascular Disease: A Large Market 
Atrial Fibrillation Chronic Heart 
Failure 
Heart Flutter Coronory Artery 
US patient population 
49 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Disease 
Hypertension 
Opportunity 
6M 
78M 
3M 
30M 
47M 
US Cardiovascular Annual Disease Expense $273 Billion
Growth in Heart Disease – 
US population 2000 - 2050 
Beller GA. Circulation. 2001; 103:2428 – 2435 
Foot DK, et.alo. J Am Coll Cardiol. 2000; 35:1067 -1081 
50 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Hypertension: The Statistics 
51 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Prevalence of Atrial Fibrillation 
Summary of studies 
investigating the prevalence of 
atrial fibrillation in various 
populations and age groups1 
% 
< 40 60 64 74 > 75 
10 
8 
6 
4 
2 
1Cairns J, Connolly J. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombetic therapy. 
Circulation. 1991:84;469. 
52 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Age (years) 
0
Annual Utilization/Primary Diagnosis 
More than $1.3 billion spent annually due to AF primary diagnosis 
Unspecified 
Conduction Disease 
Sick Sinus Syndrome 
Premature Beats 
Junctional Rhythms 
Atrial Flutter 
Atrial Fibrillation 
Ventricular Tachycardia 
Ventricular Fibrillation 
Cardiac Arrest 
0 200 400 600 800 1000 
Thousands of Hospital Days The Lancet, 1993;341:1319. 
53 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Primary Healthcare Expenditures 
Annual Economic Burden 
40 
35 
30 
25 
20 
15 
10 
5 
0 
Billions of $ US 
HF AF VT/VF Brady 
54 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
A Growing Medical Challenge 
Heart failure management 
Annual 
Incidence 
Heart Failure 
Prevalence 
400,000 5.0 million 
250,000 
6.5 million 
55 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Annual 
Mortality 
U.S. 
Europe 580,000 300,000 
Congestive heart failure worldwide markets, clinical status and product development opportunities. New Medicine, Inc. 1997:1-40. 
Wilkerson Group Survey, 1998.
mHealth Cardiology Solutions are Growing 
Rapidly 
56 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
One Small mHealth Solution: 
AliveCor Smartphone ECG 
57 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
58 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
The AliveCor Smartphone System is a Global, 
Cloud-Based ECG Monitor 
Patient Takes ECG 
Via Hands or Chest 
ECGs Securely Stored & 
Processed In the Cloud 
ECGs Stored Locally 
59 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
ANYWHERE IN 
THE WORLD 
ECGs Accessed Via 
HIPAA-compliant, 
Secure Login
In-Flight Arrhythmia Diagnosis CASE 
Patient Profile and History 
• A male patient in his mid 20’s experiences 
shortness of breath, palpitations, and chest 
pain during an intercontinental flight. Physician 
unable to diagnose rhythm with stethoscope. 
60 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
Clinical Assessment Using the Heart Monitor: 
• An ECG recorded with the Heart Monitor 
showed runs of Ventricular Trigeminy 
(Premature Ventricular Contractions every 
third beat). 
• Patient was instructed to see a doctor when 
arriving at home and take the ECG to the 
appointment 
Value of the Heart Monitor: 
• The Heart Monitor in this instance was able to assist the doctor in diagnosing PVCs. 
• This allowed the plane to continue on its journey without an expensive emergency landing to care 
for the patient. 
• The patient was given the peace of mind that their symptoms were not life threatening and could 
see their primary physician when arriving at home.
AFib Screening & Stroke Risk Identification 
Cardiologist A Cardiologist B AliveCor AF Algorithm* 
94% 95% 97% 
 109 patients evaluated with standard ECG and AliveCor 
 70 sinus rhythm, 39 AFIB 
 Blind evaluation 
Concord Hospital, University of Sydney, Australia (PI, Dr. Ben Freedman, Professor of 
Cardiology and Deputy Dean of Medicine) 
Presented at the American Heart Association in November 2012 
*AliveCor AF Algorithm in testing, not currently available for sale in the US or elsewhere 
61 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Database Currently Contains Over a Million 
ECGs- Following Them Over Time. 
Bradycardia Tachycardia 
Heart Rate Distribution From Customer Database 
62 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
mHealth Transforming Heart Health By 
Empowering Self-Care 
Traditional ECG AliveCor ECG 
 Difficult to access 
 Expensive 
 Limited to institutions 
 Appointment driven 
63 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
 Data driven 
 Instantly available 
 Accessible & affordable 
 Consumer-centric
Physician-Directed Patient Self-Management of Left Atrial 
Pressure in Advanced Chronic Heart Failure 
Ritzema J et al. Circulation. 2010;121:1086-1095 
64 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Patient Self-Management Case Study 
 Patient with atrial fibrillation (AFIB), an erratic heart beat, on the drug 
Amiodarone which causes severe side effects 
 Patient buys the AliveCor device with subscription, using it on a daily basis for 
remote monitoring 
 Patient and physician adjust prescription dosage while monitoring ECG real time 
from home, eliminating side effects and controlling AFIB 
 Expensive hospital and office visits avoided 
 Money saved for payors 
Ubiquitous ECG monitoring can transform healthcare delivery, 
reducing cost while improving outcomes! 
65 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
Veterinary mHealth Opportunity 
• From dogs & cats to horses and 
exotic animals, mHealth presents 
opportunities to take state-of-the-art 
care to the patients. 
• Vets have always made house calls 
especially for farm animals and 
horses- they are true “mobile care 
providers” 
• Owners can source biometric data 
as it’s always easier to “move data” 
than to “move patients” , especially if 
they are LARGE! 
66 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 
AliveCor Company Confidential Oct-14
Impact of Digital & Mobile Health 
Changing the paradigm – creating a new S-curve 
 Extends reach of healthcare institutions to home & mobile 
 Cellphone-based disease management improves outcomes 
 Enabled by consumer electronics cost structures and channels 
 Physicians embrace mobile monitoring for their patients 
 Patients accept ownership and financial responsibility for 
better health and wellness tools 
 Mobile health solutions present major business opportunities 
67 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
What’s Going to Happen to mHealth? 
1. Consumerization is early but it’s coming to 
cardiovascular and all healthcare. 
2. Technologies like Smartphones & Cloud 
Computing are enablers but Changing 
Economics & Increased Personal 
Responsibility are the Drivers! 
3. Change creates Opportunity so embrace it! 
THANK YOU! 
68 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.

Albert 2 oklahoma telemedicine

  • 1.
    Oklahoma Telemedicine Conference 2014 David E. Albert, MD Founder and Chief Medical Officer AliveCor The mCardiology Company 1 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 2.
    Disclaimer Statements, opinionsand results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein. 2 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 3.
    Disclosure Statement ofFinancial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company • Major Stock Shareholder/Equity • Ownership/Founder • Salary & Other Financial Benefit 3 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. • AliveCor, Inc.
  • 4.
    Objectives • Describethe current status of healthcare delivery in the US and OUS • Describe how mHealth can help address some of the global issues • Describe the current status of mHealth in the US and OUS • Provide real-world examples of how mHealth is working • Describe the potential in the future 4 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 5.
    US Healthcare Expenditures 5 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 6.
    Expenditures Continue toIncrease 6 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 7.
    7 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 8.
    Healthcare Problems DifferFor the Developed vs. the Developing World • Developed world (especially the US) spends too much on healthcare and doesn’t get its money’s worth. • Developing world spends too little and gets exactly what it pays for (i.e., almost nothing). • We must find solutions and technologies which can address the problems of both… and that’s not as crazy as it sounds! 8 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 9.
    Population Growth (inthe Developing World) Demands Action to Improve Healthcare! 9 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 10.
    10 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 11.
    Healthcare Globally MustGo from Reactive to Proactive: Hygiene & Diet & Fitness & Vaccines, Etc. 11 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 12.
    Inadequate Healthcare Access Global HC workforce vs. disease burden* The challenge 2013 12 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 57 Countries below WHO critical healthcare coverage threshold 4.3 million Worldwide shortage of health workers including doctors, nurses, and midwives $2 billion Annual cost just for training of needed U.S., Canada, and Latin America have 37% of global HC professionals in India alone healthcare workers and only 10% of global disease burden *: Size of circles proportional to healthcare expenditures Source: World Health Organization AliveCor Company Confidential Oct-14
  • 13.
    Health Data, likeAll Information, will be Shared, Connected & Engaged *: 1 exabyte = 109 gigabytes Source: Cisco VNI Mobile 2011 92% CAGR 13 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 14.
    And Exponential Changewill bring a New Paradigm to Healthcare 14 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 15.
    Smartphones Introduced Apps& As the Late Steve Jobs said, “That changed everything”! • > 1 Billion Apple and Android devices sold to date worldwide • Over 70% of US subscribers have a smartphone • 100 billion app downloads from Apple’s iTunes Store & Android Market • 5 years from now there will be no dumb phones but only smartphones 15 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 16.
    Smartphones: The GlobalTechnology Growth Engine mHealth: Bringing Smartphone Dynamics to Medicine 75 38 13 16 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 4 2.5 mHealth by 2017 Telephone Radio TV Internet Smartphone Years to reach 50 Million Users 500M $26B Users Market size
  • 17.
    The Smartphone Willbe the World’s Healthcare Portal 17 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 18.
    Smartphone ownership bydemographic group— gender, age, race/ethnicity % within each group who own a smartphone 18 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Own a smartphone All adults (n=2,252) 56% Gender Men (n=1,029) b a 59 b Women (n=1,223) 53 Age a 18-24 (n=243) 79 cdef b 25-34 (n=284) 81 cdef c 35-44 (n=292) 69 def d 45-54 (n=377) 55 ef e 55-64 (n=426) 39 f f 65+ (n=570) 18 Race/ethnicity a White, Non-Hispanic (n=1,571) 53 b Black, Non-Hispanic (n=252) 64 a c Hispanic (n=249) 60 Source: Pew R e s earch Center’s Internet m& A erican Life Projectp, A ril 17-May 19, 2013 Tracking Survey. Interviews were conducted in English and Spanish and on landline and cell phones. Margin of error is +/-2.3 percentage points based on all adults (n=2,252). Note: Percentages marked with a superscript letter (e.g., a) indicate a
  • 19.
    19 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 20.
    Smartphone ownership byincome/age grouping % within each age/income grouping who own a smartphone (example: 77% of 18-29 year olds with an annual household income of less than $30,000 are smartphone owners) 77% 47% 100% 80% 60% 40% 20% Source: Pew R e s earch Center’s Internet &m A erican Life Project 6April 2 -May 22, 2011, January 20-February 19, 2012, and April 17-May 19, 2013 tracking surveys. For 2013 data, n=2,252 adults and survey includes 1,127 cell phone interviews. All surveys include Spanish-language interviews. 20 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 22% 8% 81% 68% 40% 21% 90% 87% 72% 43% 0% 18-29 30-49 50-64 65+ Less than $30,000 $30,000-$74,999 $75,000 or more
  • 21.
    21 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 22.
    22 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 23.
    Physicians & MobileComputing Devices Source: QuantiaMD, Tablets Set to Change Medical Practice, 2011 23 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 24.
    Physicians Support MobileMonitoring • Percentage who want to monitor patients at home 24 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. 65% - Weight 61% - Blood sugar 57% - Vital signs (e.g. blood pressure, heart rate, respiratory rate) 54% - Exercise/physical activity 36% - Calories/fat content taken in 36% - Pain level 35% - Sleep patterns 28% - Cardiac rhythm 17% - Bladder control 16% - Acid reflux/indigestion 13% - Digestive health Source: PricewaterhouseCoopers HRI Physician Survey, 2010
  • 25.
    Patients Accept Ownership and Responsibility Source: IBM Report: The Future of Connected Health Devices, March 2011 “Among those surveyed, nine out of ten (93 percent) are satisfied or very satisfied with the basic functionality of their devices. Although less than 10 percent are paying out-of-pocket charges for their devices today, more than one-third expect to do so within two years. Most users are willing to pay for a device, but will not spend more than US$100 out of pocket. An increasing number of consumers also anticipate paying monthly fees in the future; while only 5 percent pay a monthly charge today, 35 percent expect to do so in two years.” AliveCor Company Confidential May 2011 25 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 26.
    Highlights A HugeOpportunity To Do Good & Do Well! PwC and GSMA predicts that global mHealth revenues will increase to $23 billion over the next four years 26 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. The market opportunity
  • 27.
    Global mHealth MarketRelevance US & Western Europe  Empower consumers  Improve effectiveness of existing systems  Reduce costs 27 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Developing World  Create health infrastructure  Leap-frog bricks and mortar  Provide accessible health solutions
  • 28.
    28 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 29.
    29 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 30.
    30 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 31.
    31 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 32.
    32 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 33.
    33 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 34.
    34 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 35.
    35 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 36.
    36 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 37.
    37 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 38.
    38 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 39.
    Outcomes are ImprovedWhen We Connect 39 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 40.
    App-Drug Synergy willEnable Patient Self-Management • Diabetes: Sanofi iBGStar • Hypertension: Withings BP • Atrial Fibrillation: AliveCor ECG 40 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 41.
    Smartphone & CloudComputing Enable Global Telemedicine 41 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 42.
    Smartphones & BigData Will Rely on CLOUD COMPUTING To Create Connected Innovations! 42 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 43.
    BIG DATA willallow innovation in everything from weather to energy to medicine! 43 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 44.
    H1N1 Virus 44© 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 45.
    1919 Spanish InfluenzaEpidemic 45 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 46.
    The New Vectorsof Social Virality 46 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 47.
    Idea Epidemics canLiterally Span the Globe in a Day 47 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 48.
    Ideas Spread Atthe Speed of Light With No Control 48 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 49.
    Cardiovascular Disease: ALarge Market Atrial Fibrillation Chronic Heart Failure Heart Flutter Coronory Artery US patient population 49 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Disease Hypertension Opportunity 6M 78M 3M 30M 47M US Cardiovascular Annual Disease Expense $273 Billion
  • 50.
    Growth in HeartDisease – US population 2000 - 2050 Beller GA. Circulation. 2001; 103:2428 – 2435 Foot DK, et.alo. J Am Coll Cardiol. 2000; 35:1067 -1081 50 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 51.
    Hypertension: The Statistics 51 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 52.
    Prevalence of AtrialFibrillation Summary of studies investigating the prevalence of atrial fibrillation in various populations and age groups1 % < 40 60 64 74 > 75 10 8 6 4 2 1Cairns J, Connolly J. Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombetic therapy. Circulation. 1991:84;469. 52 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Age (years) 0
  • 53.
    Annual Utilization/Primary Diagnosis More than $1.3 billion spent annually due to AF primary diagnosis Unspecified Conduction Disease Sick Sinus Syndrome Premature Beats Junctional Rhythms Atrial Flutter Atrial Fibrillation Ventricular Tachycardia Ventricular Fibrillation Cardiac Arrest 0 200 400 600 800 1000 Thousands of Hospital Days The Lancet, 1993;341:1319. 53 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 54.
    Primary Healthcare Expenditures Annual Economic Burden 40 35 30 25 20 15 10 5 0 Billions of $ US HF AF VT/VF Brady 54 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 55.
    A Growing MedicalChallenge Heart failure management Annual Incidence Heart Failure Prevalence 400,000 5.0 million 250,000 6.5 million 55 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Annual Mortality U.S. Europe 580,000 300,000 Congestive heart failure worldwide markets, clinical status and product development opportunities. New Medicine, Inc. 1997:1-40. Wilkerson Group Survey, 1998.
  • 56.
    mHealth Cardiology Solutionsare Growing Rapidly 56 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 57.
    One Small mHealthSolution: AliveCor Smartphone ECG 57 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 58.
    58 © 2013AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 59.
    The AliveCor SmartphoneSystem is a Global, Cloud-Based ECG Monitor Patient Takes ECG Via Hands or Chest ECGs Securely Stored & Processed In the Cloud ECGs Stored Locally 59 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. ANYWHERE IN THE WORLD ECGs Accessed Via HIPAA-compliant, Secure Login
  • 60.
    In-Flight Arrhythmia DiagnosisCASE Patient Profile and History • A male patient in his mid 20’s experiences shortness of breath, palpitations, and chest pain during an intercontinental flight. Physician unable to diagnose rhythm with stethoscope. 60 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. Clinical Assessment Using the Heart Monitor: • An ECG recorded with the Heart Monitor showed runs of Ventricular Trigeminy (Premature Ventricular Contractions every third beat). • Patient was instructed to see a doctor when arriving at home and take the ECG to the appointment Value of the Heart Monitor: • The Heart Monitor in this instance was able to assist the doctor in diagnosing PVCs. • This allowed the plane to continue on its journey without an expensive emergency landing to care for the patient. • The patient was given the peace of mind that their symptoms were not life threatening and could see their primary physician when arriving at home.
  • 61.
    AFib Screening &Stroke Risk Identification Cardiologist A Cardiologist B AliveCor AF Algorithm* 94% 95% 97%  109 patients evaluated with standard ECG and AliveCor  70 sinus rhythm, 39 AFIB  Blind evaluation Concord Hospital, University of Sydney, Australia (PI, Dr. Ben Freedman, Professor of Cardiology and Deputy Dean of Medicine) Presented at the American Heart Association in November 2012 *AliveCor AF Algorithm in testing, not currently available for sale in the US or elsewhere 61 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 62.
    Database Currently ContainsOver a Million ECGs- Following Them Over Time. Bradycardia Tachycardia Heart Rate Distribution From Customer Database 62 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 63.
    mHealth Transforming HeartHealth By Empowering Self-Care Traditional ECG AliveCor ECG  Difficult to access  Expensive  Limited to institutions  Appointment driven 63 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.  Data driven  Instantly available  Accessible & affordable  Consumer-centric
  • 64.
    Physician-Directed Patient Self-Managementof Left Atrial Pressure in Advanced Chronic Heart Failure Ritzema J et al. Circulation. 2010;121:1086-1095 64 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 65.
    Patient Self-Management CaseStudy  Patient with atrial fibrillation (AFIB), an erratic heart beat, on the drug Amiodarone which causes severe side effects  Patient buys the AliveCor device with subscription, using it on a daily basis for remote monitoring  Patient and physician adjust prescription dosage while monitoring ECG real time from home, eliminating side effects and controlling AFIB  Expensive hospital and office visits avoided  Money saved for payors Ubiquitous ECG monitoring can transform healthcare delivery, reducing cost while improving outcomes! 65 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 66.
    Veterinary mHealth Opportunity • From dogs & cats to horses and exotic animals, mHealth presents opportunities to take state-of-the-art care to the patients. • Vets have always made house calls especially for farm animals and horses- they are true “mobile care providers” • Owners can source biometric data as it’s always easier to “move data” than to “move patients” , especially if they are LARGE! 66 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential. AliveCor Company Confidential Oct-14
  • 67.
    Impact of Digital& Mobile Health Changing the paradigm – creating a new S-curve  Extends reach of healthcare institutions to home & mobile  Cellphone-based disease management improves outcomes  Enabled by consumer electronics cost structures and channels  Physicians embrace mobile monitoring for their patients  Patients accept ownership and financial responsibility for better health and wellness tools  Mobile health solutions present major business opportunities 67 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.
  • 68.
    What’s Going toHappen to mHealth? 1. Consumerization is early but it’s coming to cardiovascular and all healthcare. 2. Technologies like Smartphones & Cloud Computing are enablers but Changing Economics & Increased Personal Responsibility are the Drivers! 3. Change creates Opportunity so embrace it! THANK YOU! 68 © 2013 AliveCor, Inc. All Rights Reserved. Proprietary & Confidential.